EICHORCondition: Acute Migraine · Sponsor: Kallyope Inc.
This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.
This description comes directly from the study's public registry record.
Annemarie Vance · 917-336-3654 · annemarie@kallyope.com
Always discuss trial participation with your own doctor first.
| Central Research Associates, LLC (CRA) dba Flourish Research | Birmingham, Alabama, United States | Not Yet Recruiting |
| AMR Mobile | Mobile, Alabama, United States | Not Yet Recruiting |
| TrialSphere | Chandler, Arizona, United States | Not Yet Recruiting |
| Arkansas Clinical Research | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Axiom Research, LLC | Colton, California, United States | Not Yet Recruiting |
| ProScience Research Group | Culver City, California, United States | Not Yet Recruiting |
| Leading Edge Research LA, LLC | Encino, California, United States | Not Yet Recruiting |
| Axiom Research, Orange County | Irvine, California, United States | Not Yet Recruiting |
| Downtown L.A. Research Center, Inc. | Los Angeles, California, United States | Not Yet Recruiting |
| Clinical Research Institute | Los Angeles, California, United States | Not Yet Recruiting |
| M3 Wake Research - Mission Mental Health (WR-MMH) | Mission Viejo, California, United States | Not Yet Recruiting |
| Excell Research | Oceanside, California, United States | Not Yet Recruiting |
+ 102 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07674654